Free Trial
NYSE:TFX

Teleflex (TFX) Stock Price, News & Analysis

$220.30
-2.19 (-0.98%)
(As of 07/26/2024 ET)
Today's Range
$217.30
$223.31
50-Day Range
$198.62
$230.30
52-Week Range
$177.63
$258.89
Volume
500,418 shs
Average Volume
366,739 shs
Market Capitalization
$10.38 billion
P/E Ratio
35.36
Dividend Yield
0.62%
Price Target
$263.14

Teleflex MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
19.4% Upside
$263.14 Price Target
Short Interest
Healthy
1.37% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.53
Upright™ Environmental Score
News Sentiment
0.52mentions of Teleflex in the last 14 days
Based on 9 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.40%
From $13.75 to $15.18 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.44 out of 5 stars

Medical Sector

123rd out of 936 stocks

Surgical & Medical Instruments Industry

19th out of 101 stocks

TFX stock logo

About Teleflex Stock (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock Price History

TFX Stock News Headlines

Teleflex (TFX) Set to Announce Earnings on Thursday
How a $0.25 cent option contract makes my top traders feel
If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…
How a $0.25 cent option contract makes my top traders feel
If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…
Teleflex Publishes 2023 Global Impact Report
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/02/2024
Ex-Dividend for 6/14 Dividend
5/14/2024
Dividend Payable
6/14/2024
Today
7/26/2024
Next Earnings (Confirmed)
8/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
87936910
Employees
14,500
Year Founded
1943

Price Target and Rating

Average Stock Price Target
$263.14
High Stock Price Target
$285.00
Low Stock Price Target
$240.00
Potential Upside/Downside
+19.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$356.33 million
Pretax Margin
10.35%

Debt

Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$18.47 per share
Book Value
$94.49 per share

Miscellaneous

Free Float
46,429,000
Market Cap
$10.38 billion
Optionable
Optionable
Beta
1.13

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

TFX Stock Analysis - Frequently Asked Questions

How have TFX shares performed this year?

Teleflex's stock was trading at $249.34 at the beginning of the year. Since then, TFX stock has decreased by 11.6% and is now trading at $220.30.
View the best growth stocks for 2024 here
.

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings data on Thursday, May, 2nd. The medical technology company reported $3.21 earnings per share for the quarter, topping the consensus estimate of $3.07 by $0.14. Teleflex's quarterly revenue was up 3.8% compared to the same quarter last year.
Read the conference call transcript
.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Glassdoor.com. Liam Kelly has an approval rating of 86% among the company's employees.

Who are Teleflex's major shareholders?

Top institutional investors of Teleflex include Bank of New York Mellon Corp (0.90%), Boston Trust Walden Corp (0.50%), LGT Capital Partners LTD. (0.47%) and Ceredex Value Advisors LLC (0.26%). Insiders that own company stock include Liam Kelly, Thomas E Powell, Cameron P Hicks, Stuart A Randle and Andrew A Krakauer.
View institutional ownership trends
.

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW) and QUALCOMM (QCOM).

This page (NYSE:TFX) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners